Tag Archives: National Science Advisory Board for Biosecurity
A Risk Worth Taking?
In 2011, Anthony Fauci publicly defended dangerous gain-of-function research as a risk worth taking. Today, Americans are demanding answers about what was funded in Wuhan—and who should be held accountable. This deep dive is well worth your time.
Posted in Federal
|
Tagged Bronston v. United States, China, COVID, Cui Tiankai, David M. Morens, Dr. Anthony Fauci, Dr. Céline Gounder, EcoHealth Alliance, Francis Collins, Gary Nabel, Gerald L. Epstein, H5N1 avian influenza, Jeremy Farrar, John Holdren, mBio, National Institute of Allergy and Infectious Diseases, National Science Advisory Board for Biosecurity, Peter Daszak, President Joe Biden, Ralph Baric, Rand Paul, U.S. House Select Subcommittee on the Coronavirus Pandemic, U.S. Right To Know, Wellcome Trust, White House Office of Science and Technology Policy, Wuhan, Zhao Lijian
|
Comments Off on A Risk Worth Taking?